-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
January 01, 2007 - Layout 1
This report is an update to a Comparative
Effectiveness Review on management
strategies for renal … This report does
not address the management of
fibromuscular dysplasia, renal transplant
recipients, … For patients with atherosclerotic renal
artery stenosis in the modern
management era (i.e., since JNC … on the
effects of aggressive medical therapy
Comparative Effectiveness of Management
Strategies for Renal … Comparative
Effectiveness of Management Strategies for Renal
Artery Stenosis: 2007 Update.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - Description
Nominator: Individual
Nomination
Summary:
The nominator questions the comparative renal … diagnostic procedures requiring
the use of contrast media; subgroups of interest include patients with renal … methods,
pharmacologic strategies (e.g., Fenoldpam, Mannitol, Theophylline, natriuretic peptides),
and renal … biochemical evidence of organ function (serum creatinine or creatinine clearance),
mortality, rate of renal … What is the comparative renal safety of different contrast media used in radiographic
imaging?
-
effectivehealthcare-admin.ahrq.gov/products/sodium-potassium/research-protocol
January 01, 2019 - lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi
AND
humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi
AND
humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR
-
effectivehealthcare-admin.ahrq.gov/health-topics/kidney-cancer
July 18, 2017 - kidneycancer.html
Products
Clinician Summary Archived July 18, 2017
Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Systematic Review … Archived February 24, 2016
Management of Renal Masses and Localized Renal Cancer … Research Protocol Archived April 20, 2015
Management of Renal Masses and Localized Renal Cancer
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-johnson.pdf
August 27, 2012 - toxicity,
Efficacy,
Weight of
evidence, Renal
toxicity
Mean relative
importance
German … Patients rank
toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank
toxicity against progression-free survival in second-line treatment of advanced renal … Slide 16
Maximum Acceptable Risk Calculation
Renal Cell Carcinoma
Image: Bar chart showing 3 month … Patients rank
toxicity against progression-free survival in second-line treatment of advanced renal
-
effectivehealthcare-admin.ahrq.gov/products/kidney-stone-prevention/research-protocol
December 01, 2019 - Large struvite stones remain in the renal pelvis and may not cause pain. … Exclusion: 1) Patients with ongoing acute renal colic, 2) patients undergoing treatment to assist in … colic, acute renal failure)
Quality of life (general, urologic)
End-stage renal disease
Intermediate … calcul* or kidney stone*).mp.
3 renal colic.mp. or exp Renal Colic/
4 hypercalciuria.mp. or exp … Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - However, these renal endpoints are
not clinical outcomes. … United States Renal Data System. … Renal Disease in the United States. … Predictors of the
progression of renal disease in the Modification of Diet in Renal
Disease Study. … Renal Association.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Most important Least important
German patients Renal toxicity Weight of … Patients rank toxicity against progression-free survival in second-line
treatment of advanced renal … RTI International Research Triangle Institute
Maximum Acceptable Risk Calculation
Renal Cell Carcinoma … Patients rank toxicity against progression-free survival in second-line
treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line
treatment of advanced renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Diabetes Rate
in Enrolled
Population
Total All 2006 32.8 8.7 26.4%
Age
Disabled/end stage
renal … Indian/Alaska Native
2006 0.1 0.1 36.0%
Total All 2007 32.3 8.8 27.3%
Age Disabled/end stage
renal … Indian/Alaska Native
2007 0.2 0.1 37.3%
Total All 2008 31.9 8.9 27.9%
Age Disabled/end stage
renal … Indian/Alaska Native
2006 9.7% 28.4% 6.4%
Total All 2007 8.1% 18.9% 5.0%
Age Disabled/end stage
renal … of Major and
Minor LEA in the
Same Year
Total All 2006 1.4% 0.5% 0.3%
Age Disabled/end stage renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
April 18, 2017 - lithiasis OR nephrolith*
OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal
calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR
renal calculi
AND
humans[MESH] OR ( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR
renal calculi
AND
"Prospective Studies … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal
calculi OR "Mortality"[Mesh] OR
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor
November 01, 2017 - better organ survival rate, b) fewer rejections, c) less nephrotoxicity and/or d) cost savings in renal … better organ survival rate, b) fewer rejections, c) less nephrotoxicity, and/or d) cost savings in renal … organ survival rate, b) fewer rejection episodes, c) less nephrotoxicity,and/or d) cost savings in renal … adult renal patients
Are there subgroups of patients that your question might apply to? … In addition, 31% of deaths in renal transplant patients were deaths with a functioning graft from
co
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Beneficiaries
With Diabetes and
Without PAD
Total All 2006 6.0% 13.5% 4.0%
Age Disabled/end stage
renal … Indian/Alaska
Native
2006 6.9% 17.9% 5.0%
Total All 2007 6.0% 13.2% 4.0%
Age Disabled/end stage
renal … /Alaska
Native
2006 1.0% 5.6% 0.135%
Total All 2007 0.5% 1.9% 0.055%
Age Disabled/end stage
renal … /Alaska
Native
2007 0.8% 4.7% 0.131%
Total All 2008 0.4% 1.8% 0.058%
Age Disabled/end stage
renal … Diabetic Population
Q1 Q2 Q3 Q4
Total All 2006 0.18% 0.14% 0.12% 0.12%
Age Disabled/end stage renal
-
effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-pain/research-protocol
December 01, 2019 - -200 mg/day; RA: delayed release, 100-200 mg/day in 3 to 4 doses; extended release, 75-225 mg/day
Renal … primary dysmenorrhea; rheumatoid arthritis
OA and RA: 1200-3200 mg/day in 3 to 4 divided doses
Renal … to 3x/day or a maximum dose of 100 mg 2x/day; sustained release product, 75 mg 1 to 2x/day
Severe renal … Peds: lowest effective dose for shortest possible duration; >65 years of age or weight <50 kg or renal … ; osteoarthritis; rheumatoid arthritis
OA and RA: 7.5 mg 1x/day; maximum, 15 mg 1x/day
Elderly, renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
August 01, 2016 - Renal Disease
Nephropathy
Background
Numerous strategies have been used to try to prevent CIN,
including … Leading theories state that CIN results from hypoxic injury
of the renal tubules induced by renal vasoconstriction … ���
Development of CIN
(with IA administration)
18d 4194 ⬌ – 0.80 (0.64 to 1.01) ���
Need for renal … e Renal replacement therapy consisted of hemodialysis or hemofiltration. … g Renal replacement therapy consisted of hemodialysis or hemofiltration.
-
effectivehealthcare-admin.ahrq.gov/health-topics/high-blood-pressure
March 04, 2022 - Disease Outcomes and Related Risk Factors
Systematic Review Archived August 16, 2016
Renal … Updated Comparative Effectiveness Review
Research Protocol Archived January 20, 2015
Renal … Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage Renal … Review Archived November 19, 2007
Comparative Effectiveness of Management Strategies for Renal … Systematic Review Archived October 24, 2006
Comparative Effectiveness of Management Strategies for Renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
October 01, 2013 - Objectives for the Systematic Review
Contrast induced nephropathy (CIN) is defined as impairment of renal … If renal function returns to normal, it usually does so within 7 to 10
days after contrast medium administration … to CKD at 3 and 6 months
● Chronic change in kidney function
b) Renal disease-specific outcomes … disease; KQ=Key question;
RRT=renal replacement therapy
Source: www.effectivehealthcare.ahrq.gov … In 1% of all
patients undergoing
contrast enhanced CT the decline in
renal function persisted.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2024.pdf
January 01, 2024 - particularly important for people with
chronic kidney disease (CKD), particularly those with end-stage
renal … Including payment for dental coverage for people with end-
stage renal disease receiving dialysis removes … CMS physician fee schedule to provide oral
health coverage under Medicare for people with end-stage renal … This change may
improve outcomes for people with end-stage renal disease receiving dialysis as well
-
effectivehealthcare-admin.ahrq.gov/products/acute-pain-treatment/technical-brief
March 01, 2020 - for several acute pain conditions including postoperative pain, dental pain, neck pain, back pain, renal … overview of systematic reviews include postoperative postdischarge pain, acute back pain, acute neck pain, renal … warrant a new systematic review: pain associated with dental procedures and oral surgery, low back pain, renal … pain conditions (postdischarge postoperative pain, musculoskeletal pain, acute migraine, dental pain, renal
-
effectivehealthcare-admin.ahrq.gov/health-topics/surgery?page=0
March 10, 2025 - Cell Carcinoma of the Skin
Clinician Summary Archived July 18, 2017
Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Systematic Review … of Uterine Fibroids
Systematic Review Archived February 24, 2016
Management of Renal … Masses and Localized Renal Cancer
Pagination
1
2
3
4
5
-
effectivehealthcare-admin.ahrq.gov/health-topics/surgery
March 10, 2025 - Cell Carcinoma of the Skin
Clinician Summary Archived July 18, 2017
Management of Renal … Masses and Localized Renal Cell Carcinoma: Current State of the Evidence
Systematic Review … of Uterine Fibroids
Systematic Review Archived February 24, 2016
Management of Renal … Masses and Localized Renal Cancer
Pagination
1
2
3
4
5